Photoproduction of Aviation Fuel β‐Caryophyllene From the Eukaryotic Green Microalga Chlamydomonas reinhardtii
Biotechnology and Bioengineering · 2025
DOI: 10.1002/bit.28898 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2025. Written by Xiaotan Dou and 11 co-authors. Institution: MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, China. Major MEDLINE topics: Polycyclic Sesquiterpenes, Chlamydomonas reinhardtii, Metabolic Engineering, Sesquiterpenes. Cited 10 times so far (Crossref); 63 references. Funded by: This work was supported by Fundamental Research Funds for the Central Universities (DUT23YG210, DUT24BK033), National Natural Science Foundation of China (3190….
Abstract (original language)
β‐caryophyllene is a plant‐derived sesquiterpene and is regarded as a promising ingredient for aviation fuels. Microalgae can convert CO 2 into energy‐rich bioproducts through photosynthesis, making them potential platforms for the sustainable production of sesquiterpenes. However, heterologous sesquiterpene engineering in microalgae is still in its infancy, and β‐caryophyllene production in eukaryotic photosynthetic microorganisms has not been reported. In this study, we succeeded in producing β‐caryophyllene in the model eukaryotic microalga Chlamydomonas reinhardtii by heterologously expressing a β‐caryophyllene synthase ( QHS ). Furthermore, overexpressing the key enzyme of the 2‐C‐methyl‐D‐erythritol 4‐phosphate pathway in the QHS ‐expressing strain ( QHS‐DXS‐HDR −18) resulted in a 17‐fold higher β‐caryophyllene production compared to the single expression of QHS ( QHS −28). Additionally, when isopentenyl diphosphate isomerase ( CrIDI ) was overexpressed, the β‐caryophyllene production was up to 480.6 μg/L in QHS‐DXS‐HDR‐CrIDI −16 and increased by 1.8‐fold compared to the parental strain QHS‐DXS‐HDR −18. Under photoautotrophic and photomixotrophic conditions in photobioreactors, the β‐caryophyllene production in QHS‐DXS‐HDR‐CrIDI −16 reached 854.7 and 1016.8 μg/L, respectively. Noticeably, all the β‐caryophyllene‐producing strains generated in this study did not exhibit adverse effects on cell growth and photosynthesis activity compared to the untransformed strain. This study demonstrates the first successful attempt to produce β‐caryophyllene in the eukaryotic microalga C. reinhardtii and develops a novel strategy for increasing sesquiterpene production in eukaryotic photosynthetic microorganisms.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, China.
- Instrumental Analysis Center, Dalian University of Technology, Dalian, Liaoning, China.
- Key Laboratory of Pollution Ecology and Environmental Engineering, Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, China.
ORCID profiles: Fantao Kong
Funding
- This work was supported by Fundamental Research Funds for the Central Universities (DUT23YG210, DUT24BK033), National Natural Science Foundation of China (3190…
Cite
APA
Dou, X., Li, M., Ge, Y., Yin, G., Wang, X., Xue, S., Jia, B., Zi, L., Wan, H., Xi, Y., Chi, Z., & Kong, F. (2025). Photoproduction of Aviation Fuel β‐Caryophyllene From the Eukaryotic Green Microalga Chlamydomonas reinhardtii. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28898
Vancouver
Dou X, Li M, Ge Y, Yin G, Wang X, Xue S, et al. Photoproduction of Aviation Fuel β‐Caryophyllene From the Eukaryotic Green Microalga Chlamydomonas reinhardtii. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.28898
BibTeX
@article{Dou2025,
author = {Dou, Xiaotan and Li, Mengjie and Ge, Yunlong and Yin, Gerui and Wang, Xinyu and Xue, Song and Jia, Baolin and Zi, Lihan and Wan, Huihui and Xi, Yimei and Chi, Zhanyou and Kong, Fantao},
title = {Photoproduction of Aviation Fuel β‐Caryophyllene From the Eukaryotic Green Microalga Chlamydomonas reinhardtii},
journal = {Biotechnology and Bioengineering},
year = {2025},
doi = {10.1002/bit.28898}
}
EUVIMED